Biotech firm CSL Behring has announced the four-year results from the pivotal HOPE-B study confirming the long-term ...

Danish pharma major Novo Nordisk has announced interim results from the Phase III FRONTIER3 trial of 70 children with ...

Netherlands-based Bilthoven Biologicals, the Dutch subsidiary of the Serum Institute of India and a leading end-to-end ...

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

Shares of rare disease drug developer X4 Pharmaceuticals took a battering after it said it will restructure its workforce and ...

US CNS specialist Relmada Therapeutics has announced the acquisition of sepranolone, a Phase IIb ready neurosteroid, from ...

Alumis (Nasdaq: ALMS) and Acelyrin (Nasdaq: SLRN) have agreed to merge in an all-stock deal, creating a late-stage ...

China has issued a guideline on comprehensively deepening the reform of regulation of drugs and medical devices to promote the high-quality development of the pharmaceutical industry, the National ...

Trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has accused one of the country’s largest compounders, Hims & Hers, of running a misleading multi-million dollar Super Bowl ...

Klaus Edvardsen has been named chief medical officer (CMO) of Epitopea, an Anglo-Canadian company developing off-the-shelf RNA-based immunotherapies.

Karen Andersen, equity strategist at Morningstar, has issued an analysis of US pharma major Eli Lilly’s latest financial results, which were published yesterday.

Dr Reddy’s Laboratories has signed a licensing deal with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar of Johnson & Johnson’s (NYSE: JNJ) Darzalex (daratumumab) for ...